AXSM20260918C165
AXSM Sep 18 2026 165.00 Call (AXSM260918C00165000)
option OPRA

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.